Radiation therapy for prostate cancer in Syrian refugees: facing the need for change

Simple item page
dc.contributor.authorEren, Mehmet Fuat
dc.contributor.authorKılıç, Sarah Sabrine
dc.contributor.authorEren, Ayfer Ay
dc.contributor.authorKaplan, Sedenay Oskeroğlu
dc.contributor.authorTeke, Fatma
dc.contributor.authorKütük, Tuğçe
dc.date.accessioned2023-09-14T13:07:06Z
dc.date.available2023-09-14T13:07:06Z
dc.date.issued2023en_US
dc.departmentDicle Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Radyasyon Onkolojisi Ana Bilim Dalıen_US
dc.description.abstractPurpose: To report the utilization of radiation therapy in Syrian refugee patients with prostate cancer residing in Turkey. Methods and materials: A multi-institutional retrospective review including 14 cancer centers in Turkey was conducted to include 137 Syrian refugee patients with prostate cancer treated with radiation therapy (RT). Toxicity data was scored using the National Cancer Institute Common Terminology Criteria for Adverse Events version 3.0. Noncompliance was defined as a patient missing two or more scheduled RT appointments. Results: Advanced disease, defined as stage III or IV, was reported in 64.2% of patients while androgen deprivation therapy (ADT) was only administrated to 20% of patients. Conventionally fractionated RT with a median number of 44 fractions was delivered to all patients with curative intent (n = 61) while palliative RT (n = 76) was delivered with a median number of 10 fractions. The acute grade 3–4 toxicity rate for the entire cohort was 16%. Noncompliance rate was 42%. Conclusion: Most Syrian refugee prostate cancer patients presented with advanced disease however ADT was seldom used. Despite the low treatment compliance rate, conventional fractionation was used in all patients. Interventions are critically needed to improve screening and increase the use of standard-ofcare treatment paradigms, including hypofractionated RT and ADT.en_US
dc.identifier.citationEren, M. F., Kılıç, S. S., Eren, A. A., Kaplan, S. O., Teke, F. ve Kütük, T. (2023). Radiation therapy for prostate cancer in Syrian refugees: facing the need for change. Frontiers in Public Health, (11), 1-6.en_US
dc.identifier.doi10.3389/fpubh.2023.1172864
dc.identifier.endpage6en_US
dc.identifier.issn2296-2565
dc.identifier.issue11en_US
dc.identifier.pmid37325331
dc.identifier.scopus2-s2.0-85162044290
dc.identifier.scopusqualityQ2
dc.identifier.startpage1en_US
dc.identifier.urihttps://www.frontiersin.org/articles/10.3389/fpubh.2023.1172864/full
dc.identifier.urihttps://hdl.handle.net/11468/12563
dc.identifier.wosWOS:001006068900001
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.institutionauthorTeke, Fatma
dc.language.isoenen_US
dc.publisherFrontiers Media S.A.en_US
dc.relation.ispartofFrontiers in Public Health
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectGlobal healthen_US
dc.subjectProstate canceren_US
dc.subjectRadiation therapyen_US
dc.subjectRefugeeen_US
dc.subjectSyriaen_US
dc.subjectTurkeyen_US
dc.titleRadiation therapy for prostate cancer in Syrian refugees: facing the need for changeen_US
dc.titleRadiation therapy for prostate cancer in Syrian refugees: facing the need for change
dc.typeArticleen_US

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Radiation therapy for prostate cancer in Syrian refugees Facing the need for change.pdf
Size:
253.28 KB
Format:
Adobe Portable Document Format
Description:
Makale Dosyası
Download
License bundle
Now showing 1 - 1 of 1
[ X ]
Name:
license.txt
Size:
1.44 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Dahili Tıp Bilimleri Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu

We collect and process your personal information for the following purposes: Authentication, Preferences, Acknowledgement and Statistics.
To learn more, please read our privacy policy.

Customize